首页> 美国卫生研究院文献>Marine Drugs >Apo-9′-Fucoxanthinone Isolated from Sargassum muticum Inhibits CpG-Induced Inflammatory Response by Attenuating the Mitogen-Activated Protein Kinase Pathway
【2h】

Apo-9′-Fucoxanthinone Isolated from Sargassum muticum Inhibits CpG-Induced Inflammatory Response by Attenuating the Mitogen-Activated Protein Kinase Pathway

机译:从鼠尾草中分离出的Apo-9-Fucoxanthinoneone通过减轻有丝分裂原激活的蛋白激酶途径抑制CpG诱导的炎症反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sargassum muticum (S. muticum) is a brown edible alga and widely distributed in Korea. This report was designed to evaluate the anti-inflammatory properties of apo-9′-fucoxanthinone (APO-9′) isolated from S. muticum on pro-inflammatory cytokine production. S. muticum extract (SME) exhibited significant inhibitory effects on pro-inflammatory cytokine production in bone marrow-derived macrophages (BMDMs) and dendritic cells (BMDCs). APO-9′ pre-treatment in the CpG DNA-stimulated BMDMs and BMDCs showed a strong dose-dependent inhibitory effect on interleukin (IL)-12 p40, IL-6 and tumor necrosis factor (TNF)-α production with IC50 values ranging from 5.31 to 13.79. It exhibited a strong inhibitory effect on the phosphorylation of ERK1/2 and on activator protein (AP)-1 reporter activity. APO-9′ pre-treatment exhibited significant inhibition of CpG DNA-induced production of inducible nitric oxide synthase. Taken together, these data suggest that SME and APO-9′ have a significant anti-inflammatory property and warrant further studies concerning the potentials of SME and APO-9′ for medicinal use.
机译:Sargassum muticum(S. muticum)是一种棕色的食用藻类,在韩国广泛分布。该报告旨在评估从粘液链球菌中分离的apo-9'-岩藻黄酮(APO-9')对促炎细胞因子产生的抗炎特性。鼠伤寒沙门氏菌提取物(SME)对骨髓源性巨噬细胞(BMDM)和树突状细胞(BMDC)中促炎性细胞因子的产生具有显着的抑制作用。在CpG DNA刺激的BMDM和BMDC中进行APO-9'预处理对白介素(IL)-12 p40,IL-6和肿瘤坏死因子(TNF)-α产生强烈的剂量依赖性抑制作用,IC50值在从5.31到13.79。它对ERK1 / 2的磷酸化和激活蛋白(AP)-1报告基因活性表现出强烈的抑制作用。 APO-9'预处理显示出对CpG DNA诱导的可诱导型一氧化氮合酶产生的显着抑制作用。综上所述,这些数据表明SME和APO-9'具有显着的抗炎特性,因此有必要进一步研究SME和APO-9'在医学上的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号